Trinity Biotech plc reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 14.7 million compared to USD 14.83 million a year ago. Net loss was USD 3.32 million compared to USD 5.81 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 USD | -3.47% | -27.75% | +16.55% |
Jun. 18 | Gamida Cell Names Rory Nealon as Chief Financial Officer | CI |
Jun. 17 | Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.55% | 24.52M | |
-10.93% | 11.41B | |
-11.84% | 7.53B | |
+33.21% | 5.62B | |
+4.38% | 5.54B | |
-17.33% | 3.82B | |
+7.01% | 2.6B | |
-65.28% | 2.37B | |
-10.17% | 2.26B | |
+25.34% | 2.16B |
- Stock Market
- Equities
- TRIB Stock
- News Trinity Biotech plc
- Trinity Biotech plc Reports Earnings Results for the First Quarter Ended March 31, 2024